Regeneron Pharmaceuticals, Inc. officer Joseph J Larosa sells $4.31M in stock
The officer sold at an average of $965.49 a share, according to a Form 4 filed with the SEC on Nov 4. Information only, not investment advice.
Joseph J Larosa sold about $4.3 million of Regeneron Pharmaceuticals, Inc. (REGN) stock on Nov 2, according to an SEC filing. The officer received an average of $965.49 for 4,466 shares.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. After the trade, the filing lists 38,906 shares held.
The trade was reported within two business days, as Section 16 requires.
Details from the SEC filing:
| Company | Regeneron Pharmaceuticals, Inc. (REGN) |
|---|---|
| Insider | Joseph J Larosa |
| Role | EVP General Counsel and Secret |
| Transaction | Open-market sale (code S) |
| Shares | 4,466 |
| Average price | $965.49 |
| Value | $4,311,890 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 4, 2026, 4:04 PM ET |
| Shares held after | 38,906 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
Open the full breakdown of this REGN trade
Browse the latest insider selling · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Regeneron Pharmaceuticals, Inc. director Christine A. Poon sells 7,830 shares worth $7.59M
- Insider Trading News
Regeneron Pharmaceuticals, Inc. insider George L. Sing sells $20.4M in REGN shares
- Insider Trading News
Three Regeneron Pharmaceuticals, Inc. insiders sell $32.3M of stock within one day
- Insider Trading News
Christine Ring, a chief legal officer at Nurix Therapeutics, Inc., sells $103,986 of stock
- Insider Trading News
Insider buying and selling on Nov 4: Orbimed Advisors LLC leads with $15M
